Funds holding Allogene Therapeutics Inc
141 funds declare a position · 22 ETFs and 119 other funds · 120.5M $ · US0197701065
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 101 | U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 12,134 | 29.6K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 102 | WisdomTree BioRevolution Fund WisdomTree Trust | 11,574 | 28.2K $ | 1.25 % | as of Mar 31, 2026 · Original filing |
| 103 | Nationwide Small Cap Index Fund Nationwide Mutual Funds | 11,478 | 24.4K $ | 0.01 % | as of Apr 30, 2026 · Original filing |
| 104 | Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 10,631 | 25.9K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 105 | ProShares Ultra Nasdaq Biotechnology ProShares Trust | 10,377 | 28.8K $ | 0.03 % | as of Feb 28, 2026 · Original filing |
| 106 | VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 10,375 | 25.3K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 107 | LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 10,092 | 24.6K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 108 | VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 9,870 | 27.4K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 109 | Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 9,820 | 24K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 110 | ProShares Ultra Russell2000 ProShares Trust | 9,521 | 26.5K $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 111 | ProShares UltraPro Russell2000 ProShares Trust | 9,491 | 26.4K $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 112 | SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 8,990 | 21.9K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 113 | Small-Cap Equity Portfolio PACIFIC SELECT FUND | 7,237 | 17.7K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 114 | LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 7,123 | 17.4K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 115 | ProShares Russell 2000 High Income ETF ProShares Trust | 6,663 | 18.5K $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 116 | Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 6,234 | 13.3K $ | 0.00 % | as of Apr 30, 2026 · Original filing |
| 117 | iShares Total U.S. Stock Market Index Fund BlackRock Funds | 5,719 | 12.2K $ | 0.00 % | as of Apr 30, 2026 · Original filing |
| 118 | EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 5,657 | 13.8K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 119 | SmallCap Value Fund II Principal Funds, Inc | 5,158 | 11K $ | 0.00 % | as of Apr 30, 2026 · Original filing |
| 120 | Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 5,063 | 14.1K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 121 | Total Stock Market Index Trust John Hancock Variable Insurance Trust | 4,082 | 10K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 122 | AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 4,027 | 9.8K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 123 | VIP Total Market Index Portfolio Variable Insurance Products Fund II | 3,917 | 9.6K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 124 | State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 3,701 | 9K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 125 | Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 3,487 | 9.7K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 126 | Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 2,848 | 6.1K $ | 0.04 % | as of Apr 30, 2026 · Original filing |
| 127 | Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,800 | 6.8K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 128 | TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 2,417 | 5.9K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 129 | ULTRA SMALL CAP PROFUND ProFunds | 1,760 | 3.7K $ | 0.01 % | as of Apr 30, 2026 · Original filing |
| 130 | State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,415 | 3.5K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 131 | Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,319 | 3.2K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 132 | Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 773 | 1.9K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 133 | PROFUND VP ULTRA SMALL CAP ProFunds | 521 | 1.3K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 134 | PROFUND VP SMALL CAP ProFunds | 394 | 961.4 $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 135 | Russell 2000 Fund Rydex Series Funds | 356 | 868.6 $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 136 | SMALL-CAP PROFUND ProFunds | 284 | 604.9 $ | 0.01 % | as of Apr 30, 2026 · Original filing |
| 137 | Russell 2000 1.5x Strategy Fund Rydex Series Funds | 211 | 514.8 $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 138 | ProShares Hedge Replication ETF ProShares Trust | 158 | 439.2 $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 139 | Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 154 | 375.8 $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 140 | ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 48 | 133.4 $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 141 | Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 40 | 97.6 $ | 0.00 % | as of Mar 31, 2026 · Original filing |
Institutional managers
202 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Pfizer Inc | 22,032,040 | 49.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 19,091,095 | 46.6M $ | as of Mar 31, 2026 |
| TPG GP A, LLC | 18,716,306 | 45.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 8,660,306 | 21.1M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 8,379,840 | 20.4M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 6,793,620 | 16.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 5,375,456 | 13.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,124,178 | 10.1M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 3,796,668 | 9.3M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 3,501,078 | 8.5M $ | as of Mar 31, 2026 |
| Patient Square Capital LP | 3,450,000 | 8.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 3,447,984 | 8.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,322,053 | 8.1M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 2,997,318 | 7.3M $ | as of Mar 31, 2026 |
| Wildcat Capital Management, LLC | 2,920,787 | 7.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,766,244 | 6.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,763,776 | 6.7M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 2,725,000 | 6.6M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 2,484,780 | 6.1M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 2,315,092 | 5.6M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 2,242,933 | 5.5M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 2,139,328 | 5.2M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,134,473 | 5.2M $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,013,508 | 4.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,604,090 | 3.9M $ | as of Mar 31, 2026 |